John C. Reed
Director, PHARMION CORP.
Companies
- MADRIGAL PHARMACEUTICALS, INC.Board member Aug 18, 2026 to now1
- Johnson & JohnsonEVP, Pharmaceuticals R&D Apr 13, 2023 to now2
- IONIS PHARMACEUTICALS INCBoard member Jul 5, 2006 to Sep 6, 20123
- Clovis OncologyBoard member Nov 15, 2011 to Jun 15, 20124
- Repros TherapeuticsBoard member Oct 1, 2008 to May 22, 20095
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Johnson & Johnson JNJ24,911 shares6$6.4M at $256.45May 1, 2026- MADRIGAL PHARMACEUTICALS, INC. MDGL647 shares7$288.0K at $445.11Aug 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 15, 2026Granted 647 shares of MADRIGAL PHARMACEUTICALS, INC.7
- May 1, 2026Shares withheld for tax 11,002 shares at $229.85 of Johnson & Johnson6
- May 1, 2026Exercised options 25,255 shares of Johnson & Johnson6
- Feb 17, 2026Sold 2,283 shares at $243.00 of Johnson & Johnson8
- Feb 17, 2026Sold 29,927 shares at $243.00 of Johnson & Johnson8
- Feb 17, 2026Exercised options 29,927 shares at $156.15 of Johnson & Johnson8
- Feb 17, 2026Sold 21,721 shares at $243.00 of Johnson & Johnson8
- Feb 17, 2026Exercised options 21,721 shares at $157.92 of Johnson & Johnson8
- Feb 15, 2026Shares withheld for tax 528 shares at $243.45 of Johnson & Johnson8
- Feb 15, 2026Exercised options 1,847 shares of Johnson & Johnson8
- Feb 15, 2026Shares withheld for tax 385 shares at $243.45 of Johnson & Johnson8
- Feb 15, 2026Exercised options 1,349 shares of Johnson & Johnson8
- Oct 17, 2025Sold 21,721 shares at $192.71 of Johnson & Johnson9
- Oct 17, 2025Exercised options 21,721 shares at $157.92 of Johnson & Johnson9
- Jul 17, 2025Sold 19,137 shares at $163.55 of Johnson & Johnson10
- May 1, 2025Shares withheld for tax 11,002 shares at $156.31 of Johnson & Johnson11
- May 1, 2025Exercised options 25,255 shares of Johnson & Johnson11
- Feb 18, 2025Shares withheld for tax 385 shares at $156.15 of Johnson & Johnson12
- Feb 15, 2025Exercised options 1,350 shares of Johnson & Johnson12
- May 1, 2024Shares withheld for tax 10,984 shares at $144.59 of Johnson & Johnson13
- May 1, 2024Shares withheld for tax 10,984 shares at $144.59 of Johnson & Johnson14
- May 1, 2024Exercised options 22,255 shares of Johnson & Johnson13
- May 1, 2024Exercised options 25,255 shares of Johnson & Johnson14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARClovis Oncology, Board member
- 5SEC EDGARRepros Therapeutics, Board member
- 6
- 7
- 8SEC EDGARForm 4 filed Feb 18, 2026
- 9SEC EDGARForm 4 filed Oct 20, 2025
- 10SEC EDGARForm 4 filed Jul 18, 2025
- 11SEC EDGARForm 4 filed May 5, 2025
- 12SEC EDGARForm 4 filed Feb 18, 2025
- 13SEC EDGARForm 4 filed May 3, 2024
- 14SEC EDGARForm 4 filed Oct 31, 2024